Company intelligence / Profile preview

Pharmaceutical Laboratories Cana S.A.

Athens (Iraklio), Attica, Greecebloomberg.com ↗

Ownership: Private
Employees: ~52
Development stage: Commercial

Overview

Cana is a Greek pharmaceutical company that manufactures, sells, distributes, and markets original branded products. It has established itself in hospitals for total intravenous anesthesia with Diprivan and the innovative antibiotic Meronem[1][5].

Therapeutic areas: OncologyCardiovascular
Modalities: Pharmaceuticalsfood supplementscosmeticsbiocidesmedical devices
Industry: Biotech

Partnerships

AstraZenecaJanssenMerckViatrisNestléUnileverP&GMedtronicStrykerZenecaSeven SeasFissanRiker LaboratoriesMolecular Products

Beyond the preview

Go deeper on Pharmaceutical Laboratories Cana S.A..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmaceutical Laboratories Cana S.A..

Explore the full profile